Page last updated: 2024-11-04

gatifloxacin and Urethritis

gatifloxacin has been researched along with Urethritis in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamasuna, R1
Takahashi, S1
Kiyota, H1
Yasuda, M1
Hayami, H1
Arakawa, S1
Tomono, K1
Matsumoto, T1

Trials

1 trial available for gatifloxacin and Urethritis

ArticleYear
Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial.
    Sexually transmitted infections, 2011, Volume: 87, Issue:5

    Topics: Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Gatifloxacin; Hu

2011